HCM
SLXNW

Highbridge Capital Management’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Highbridge Capital Management’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Hold
0
– -$3.51K – 327
2024
Q3 		– Hold
0
– – – 317